Diabetic Retinopathy in the US —Where We Are Now and What Is Next

The diabetes pandemic is a well-recognized public health issue. Efforts for prevention at all levels, primary, secondary, and tertiary, are needed to curb the increasing pandemic. Current knowledge of the magnitude of disease prevalence is a first step to develop cost-effective prevention strategies in any country. The article in this issue of JAMA Ophthalmology by Lundeen et al fills such an epidemiological knowledge gap by focusing on the current burden of diabetes-related ocular comorbidity in the US and by providing updated national estimates of prevalence rates of diabetic retinopathy (DR) and vision-threatening DR (VTDR) in patients with diabetes and absolute numbers of people with DR and VTDR in the US in 2021. They also report estimates for subgroups stratified by age, sex and gender, and race and ethnicity, as well as by state and county.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research